  Founded in 1992, the Company’s product pipeline comprises more than 43 partnered and proprietary antibody therapeutic development programs. Since this time, the Company has entered into several partnerships with renowned companies from the pharmaceuticals and biotechnology sector, including: Astellas Pharma, Bayer Schering Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, Centocor/Johnson&Johnson, Daiichi Sankyo, Eli Lilly, F. Hoffmann-La Roche, GPC Biotech, ImmunoGen, Merck & Co., Novartis, OncoMed Pharmaceuticals, Pfizer, Schering-Plough, Shionogi. MorphoSys headquarters is located in Martinsried /Munich, Germany. Additional facilities are located in Oxford/UK and Raleigh/USA. The Company has led the emergence of the biotechnology sector in Germany and now plays a key role globally in the human antibody sector. | 
